Login / Signup

IgG3 regulates tissue-like memory B cells in HIV-infected individuals.

Lela KardavaHaewon SohnChristine YounJames W AustinWei WangClarisa M BucknerJ Shawn JustementValerie A MelsonGwynne E RothMarissa A HandKathleen R GittensRichard W KwanMichael C SnellerYuxing LiTae-Wook ChunPeter D SunSusan K PierceSusan L Moir
Published in: Nature immunology (2018)
Immunoglobulin G3 (IgG3) has an uncertain role in the response to infection with and vaccination against human immunodeficiency virus (HIV). Here we describe a regulatory role for IgG3 in dampening the immune system-activating effects of chronic HIV viremia on B cells. Secreted IgG3 was bound to IgM-expressing B cells in vivo in HIV-infected chronically viremic individuals but not in early-viremic or aviremic individuals. Tissue-like memory (TLM) B cells, a population expanded by persistent HIV viremia, bound large amounts of IgG3. IgG3 induced clustering of B cell antigen receptors (BCRs) on the IgM+ B cells, which was mediated by direct interactions between soluble IgG3 and membrane IgM of the BCR (IgM-BCR). The inhibitory IgG receptor CD32b (FcγRIIb), complement component C1q and inflammatory biomarker CRP contributed to the binding of secreted IgG3 onto IgM-expressing B cells of HIV-infected individuals. Notably, IgG3-bound TLM B cells were refractory to IgM-BCR stimulation, thus demonstrating that IgG3 can regulate B cells during chronic activation of the immune system.
Keyphrases
  • hiv infected
  • antiretroviral therapy
  • human immunodeficiency virus
  • hiv positive
  • hepatitis c virus
  • hiv aids
  • acute lymphoblastic leukemia
  • hiv testing
  • drug induced
  • oxidative stress
  • working memory
  • binding protein